Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structural Protein Function01:56

Structural Protein Function

30.1K
Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity.  In bones and teeth, it mineralizes to...
30.1K
Structural Protein Function01:56

Structural Protein Function

3.3K
No description available
3.3K
Mechanical Protein Functions01:58

Mechanical Protein Functions

5.7K
Proteins perform many mechanical functions in a cell. These proteins can be classified into two general categories- proteins that generate mechanical forces and proteins that are subjected to mechanical forces. Proteins providing mechanical support to the structure of the cell, such as keratin, are subjected to mechanical force, whereas proteins involved in cell movement and transport of molecules across cell membranes, such as an ion pump, are examples of generating mechanical force. 
5.7K
Molecular Shapes01:18

Molecular Shapes

62.5K
Molecules have characteristic shapes that are crucial for their function. The arrangement of various electron groups around the central atom dictates their molecular geometry. Electron pairs in the valence shell of a central atom will adopt an arrangement that minimizes repulsions between the electron pairs by maximizing the distance between them. The valence electrons form either bonding pairs, located primarily between bonded atoms, or lone pairs.
Two regions of electron density in a diatomic...
62.5K
Common Ion Effect03:24

Common Ion Effect

47.1K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
47.1K
Molecular Shape and Polarity03:37

Molecular Shape and Polarity

76.1K
Dipole Moment of a Molecule
76.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cisplatin resistance in an ovarian cancer model is mediated by microtubule dynamics regulator TPPP3 in synergy with tubulin code rewiring.

Cell reports·2026
Same author

A whole genomic CRISPR-Cas9 screen identifies the amino acid transporter SLC43A1 (LAT3) as a major determinant of oxaliplatin sensitivity in colorectal cancer cells.

Molecular cancer therapeutics·2026
Same author

Functional implications of the conformational landscape of a multidrug transporter revealed by Zebrafish Abcb4 structures.

Nature communications·2026
Same author

Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters.

Cancer drug resistance (Alhambra, Calif.)·2026
Same author

Self-Assembled Verteporfin Nanoparticles for Photodynamic and Light-Independent Therapy in Glioblastoma.

Advanced nanobiomed research·2026
Same author

Phase 1 study evaluating the safety, preliminary efficacy, and pharmacodynamics of recombinant interleukin-15 in combination with nivolumab and ipilimumab in patients with refractory cancers.

Journal for immunotherapy of cancer·2025

Related Experiment Video

Updated: Feb 15, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.0K

A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.

King Leung Fung1, Michael M Gottesman

  • 1Laboratory of Cell Biology, Center of Cancer Research, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Room 2108, Bethesda, MD 20892-4254, USA.

Biochimica Et Biophysica Acta
|March 17, 2009
PubMed
Summary

The MDR1 (ABCB1) gene's 3435C>T polymorphism and its associated haplotype influence drug response and disease susceptibility. This review explores recent findings and a potential ribosome stalling mechanism affecting MDR1 transporter function.

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.4K
Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold
09:37

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold

Published on: October 23, 2015

13.5K

Related Experiment Videos

Last Updated: Feb 15, 2026

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

2.0K
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.4K
Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold
09:37

Fabrication of a Bioactive, PCL-based "Self-fitting" Shape Memory Polymer Scaffold

Published on: October 23, 2015

13.5K

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Genetics

Background:

  • The MDR1 (ABCB1) gene encodes a transporter protein crucial for cellular defense against toxins.
  • Overexpression of MDR1 in cancer cells leads to multidrug resistance, hindering chemotherapy efficacy.
  • MDR1 activity impacts drug pharmacokinetics, influencing treatment outcomes.

Purpose of the Study:

  • To review recent findings on the MDR1 3435C>T polymorphism and its associated haplotype.
  • To explore the role of these genetic variations in drug response and disease susceptibility.
  • To discuss a potential molecular mechanism involving ribosome stalling.

Main Methods:

  • Literature review of studies on MDR1 polymorphisms and haplotypes.
  • Analysis of existing data on the frequency and impact of the 3435C>T polymorphism.
  • Discussion of proposed molecular mechanisms.

Main Results:

  • The MDR1 3435C>T polymorphism, often linked with 1236C>T and 2677G>T, forms a common haplotype.
  • The frequency of the 3435C>T polymorphism varies significantly across ethnic groups.
  • Evidence suggests this haplotype influences drug response and disease susceptibility.

Conclusions:

  • The MDR1 3435C>T polymorphism and its haplotype are significant factors in pharmacogenomics.
  • Understanding these variations can personalize drug therapy and disease risk assessment.
  • Ribosome stalling is a proposed mechanism for altered MDR1 protein function due to genetic variations.